JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Atherosclerosis

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ATHEROSCLEROSIS.2005.02.017PMID 16159599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.

  2004cited by this paper
• Transactivation of KDR/Flk-1 by the B2 Receptor Induces Tube Formation in Human Coronary Endothelial Cells

  2003cited by this paper
• Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway.

  2003cited by this paper
• Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

  2003cited by this paper
• Regulation of C2C12 myogenic terminal differentiation by MKK3/p38α pathway

  2003cited by this paper
• High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells

  2003cited by this paper
• Distinct Regulation of Mitogen-activated Protein Kinases and p27Kip1 in Smooth Muscle Cells from Different Vascular Beds

  2003cited by this paper
• Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study

  2002cited by this paper
• Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.

  2002cited by this paper
• Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage.

  2002cited by this paper
• Multiple roles of the tumor suppressor p53

  2002cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Ligand‐independent signals from angiotensin II type 2 receptor induce apoptosis

  2000cited by this paper
• PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

  2000cited by this paper
• A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

  2000cited by this paper
• Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody.

  2000cited by this paper
• Atmospheric carbon dioxide concentrations over the past 60 million years

  2000cited by this paper
• Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

  1999cited by this paper
• Therapeutic angiogenesis for heart failure

  1999cited by this paper
• A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.

  1998cited by this paper
• Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits*

  1998cited by this paper
• Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

  1997cited by this paper
• Three distinct signalling responses by murine fibroblasts to genotoxic stress

  1996cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Plasma lipid transfer proteins.

  1995cited by this paper
• Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies.

  1994cited by this paper
• Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1

  1994cited by this paper
• Fitness: Historical perspective

  1992cited by this paper
• Angiogenesis in atherosclerosis.

  1992cited by this paper
• Apoptosis and Heart Failure: A Critical Review of the Literature Vascular Cell Apoptosis in Remodeling, Restenosis, and Plaque Rupture

  year unknowncited by this paper

• MEK inhibitors: a promising targeted therapy for cardiovascular disease

  2024cites this paper
• In vivo evaluation of a pro-healing polydopamine coated stent through an in-stent restenosis rat model.

  2020cites this paper
• Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.

  2014cites this paper
• The influence of high glucose on the Cip/Kip family expression profiles in HRECs

  2013cites this paper
• Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood.

  2013cites this paper
• In stent restenosis and thrombosis assessment after EP224283 injection in a rat model.

  2013cites this paper
• Resténose intra-stent : évaluation de nouvelles thérapeutiques in vivo et élaboration d’un modèle in vitro hémodynamique

  2012cites this paper
• On-and Off-Target Pharmacology of Torcetrapib

  2012cites this paper
• PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.

  2011cites this paper
• PYK 2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation

  2011cites this paper
• Is a blood pressure rise the only deleterious off-target effect of cholesterol ester transfer protein inhibitors?

  2010cites this paper
• The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats.

  2010cites this paper
• Antiproliferative Activity of Larrea Divaricata Cav. on Lymphoma Cell Line: Participation of Hydrogen Peroxide in Its Action

  2010cites this paper
• The end of the road for CETP inhibitors after torcetrapib?

  2009cites this paper
• Do pressor effects explain torcetrapib ’ s failure to reduce cardiovascular disease events ?

  2009cites this paper
• Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors

  2009cites this paper
• Jun N-terminal kinase inhibitor blocks angiogenesis by blocking VEGF secretion and an MMP pathway.

  2008cites this paper
• Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy

  2007cites this paper
• Regulation of angiogenesis and angiogenic factors by cardiovascular medications.

  2007cites this paper
• Levels of p27kip1 determine Aplidin sensitivity

  2007cites this paper
• Cholesteryl ester transfer protein inhibitors as potential new therapies for coronary artery disease

  2006cites this paper
• Targeting c-Myc, Ras and IGF Cascade to Treat Cancer and Vascular Disorders

  2006cites this paper
• Molecular Mechanism of Adaphostin-mediated G1 Arrest in Prostate Cancer (PC-3) Cells

  2006cites this paper